Osseous metastases

Drugs that enhance bone integrity and prevent adverse skeletal events

James M. Heun, Aminah Jatoi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

More than 400,000 cancer patients in the USA contend with bone metastases on an annual basis. These patients often suffer pain, a decline in quality of life, and a shortened survival. As a result, over the past several years, efforts to enhance bone integrity in patients with osseus metastases have become a major research priority. This review discusses the evolving role of bisphosphonates and their side effects, highlights other pharmacological interventions aimed at enhancing bone integrity, and reviews other pragmatic approaches to prevent worsening pain and fractures, as derived from a single institution case series of patients with problematic rib metastases.

Original languageEnglish (US)
Pages (from-to)723-726
Number of pages4
JournalExpert Opinion on Pharmacotherapy
Volume10
Issue number5
DOIs
StatePublished - Apr 2009

Fingerprint

Neoplasm Metastasis
Bone and Bones
Pharmaceutical Preparations
Pain
Diphosphonates
Ribs
Quality of Life
Pharmacology
Survival
Research
Neoplasms
Osseus

Keywords

  • Adverse skeletal events
  • Bisphosphonates
  • Bone pain
  • Fracture
  • Osseous metastases
  • Rib

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Osseous metastases : Drugs that enhance bone integrity and prevent adverse skeletal events. / Heun, James M.; Jatoi, Aminah.

In: Expert Opinion on Pharmacotherapy, Vol. 10, No. 5, 04.2009, p. 723-726.

Research output: Contribution to journalArticle

@article{83836881fd9e4901b9112043ad7aa31c,
title = "Osseous metastases: Drugs that enhance bone integrity and prevent adverse skeletal events",
abstract = "More than 400,000 cancer patients in the USA contend with bone metastases on an annual basis. These patients often suffer pain, a decline in quality of life, and a shortened survival. As a result, over the past several years, efforts to enhance bone integrity in patients with osseus metastases have become a major research priority. This review discusses the evolving role of bisphosphonates and their side effects, highlights other pharmacological interventions aimed at enhancing bone integrity, and reviews other pragmatic approaches to prevent worsening pain and fractures, as derived from a single institution case series of patients with problematic rib metastases.",
keywords = "Adverse skeletal events, Bisphosphonates, Bone pain, Fracture, Osseous metastases, Rib",
author = "Heun, {James M.} and Aminah Jatoi",
year = "2009",
month = "4",
doi = "10.1517/14656560902832684",
language = "English (US)",
volume = "10",
pages = "723--726",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Osseous metastases

T2 - Drugs that enhance bone integrity and prevent adverse skeletal events

AU - Heun, James M.

AU - Jatoi, Aminah

PY - 2009/4

Y1 - 2009/4

N2 - More than 400,000 cancer patients in the USA contend with bone metastases on an annual basis. These patients often suffer pain, a decline in quality of life, and a shortened survival. As a result, over the past several years, efforts to enhance bone integrity in patients with osseus metastases have become a major research priority. This review discusses the evolving role of bisphosphonates and their side effects, highlights other pharmacological interventions aimed at enhancing bone integrity, and reviews other pragmatic approaches to prevent worsening pain and fractures, as derived from a single institution case series of patients with problematic rib metastases.

AB - More than 400,000 cancer patients in the USA contend with bone metastases on an annual basis. These patients often suffer pain, a decline in quality of life, and a shortened survival. As a result, over the past several years, efforts to enhance bone integrity in patients with osseus metastases have become a major research priority. This review discusses the evolving role of bisphosphonates and their side effects, highlights other pharmacological interventions aimed at enhancing bone integrity, and reviews other pragmatic approaches to prevent worsening pain and fractures, as derived from a single institution case series of patients with problematic rib metastases.

KW - Adverse skeletal events

KW - Bisphosphonates

KW - Bone pain

KW - Fracture

KW - Osseous metastases

KW - Rib

UR - http://www.scopus.com/inward/record.url?scp=67649591938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649591938&partnerID=8YFLogxK

U2 - 10.1517/14656560902832684

DO - 10.1517/14656560902832684

M3 - Article

VL - 10

SP - 723

EP - 726

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 5

ER -